share_log

康哲藥業：董事會會議通告

CMS: Notice of Board Meeting

香港交易所 ·  Mar 15 17:20
Summary by Futu AI
康哲药业（CMS）董事會宣布將於2024年3月27日（星期三）召開會議，屆時將考慮及擬批准公司及其附屬公司截至2023年12月31日止之年度業績，並將考慮派發末期股息。該會議將由董事會主席林剛先生主持，董事會成員還包括執行董事陳洪兵先生及陳燕玲女士，以及獨立非執行董事梁創順先生、羅瑩女士及馮征先生。
康哲药业（CMS）董事會宣布將於2024年3月27日（星期三）召開會議，屆時將考慮及擬批准公司及其附屬公司截至2023年12月31日止之年度業績，並將考慮派發末期股息。該會議將由董事會主席林剛先生主持，董事會成員還包括執行董事陳洪兵先生及陳燕玲女士，以及獨立非執行董事梁創順先生、羅瑩女士及馮征先生。
The Board of Directors of Conge Pharmaceuticals (CMS) announces that a meeting will be held on Wednesday, March 27, 2024, at which time it will consider and approve the results of the Company and its subsidiaries for the year ended December 31, 2023, and will consider the issuance of a final dividend. THE MEETING WILL BE HOSTED BY MR. LIN KANG, CHAIRMAN OF THE BOARD, AND BOARD MEMBERS WILL ALSO INCLUDE EXECUTIVE DIRECTORS MR. CHAN HUNG BING AND MS. CHAN YANLING, AS WELL AS INDEPENDENT NON-EXECUTIVE DIRECTORS MR. LEUNG CHUNG SHUN, MS. LAO YING AND MR. FUNG ZHENG.
The Board of Directors of Conge Pharmaceuticals (CMS) announces that a meeting will be held on Wednesday, March 27, 2024, at which time it will consider and approve the results of the Company and its subsidiaries for the year ended December 31, 2023, and will consider the issuance of a final dividend. THE MEETING WILL BE HOSTED BY MR. LIN KANG, CHAIRMAN OF THE BOARD, AND BOARD MEMBERS WILL ALSO INCLUDE EXECUTIVE DIRECTORS MR. CHAN HUNG BING AND MS. CHAN YANLING, AS WELL AS INDEPENDENT NON-EXECUTIVE DIRECTORS MR. LEUNG CHUNG SHUN, MS. LAO YING AND MR. FUNG ZHENG.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.